APA
HURA

Allegiant Private Advisors’s TuHURA Biosciences HURA Stock Holding History

Allegiant Private Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$41K Hold
10
– – 0.01% 164
2021
Q1 		$31K Hold
10
– – 0.01% 151
2020
Q4 		$23K Buy
+10
New +$25.1K ﹤0.01% 141

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GSEP
Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allegiant Private Advisors's HURA Position: Q2 2021 in Review

Allegiant Private Advisors held its TuHURA Biosciences (HURA) position steady in Q2 2021 at 10 shares worth $41K. The position accounts for 0.01% of the portfolio, ranked #164.

Allegiant Private Advisors first reported a position in HURA in Q4 2020 and has held it in 3 quarters since. 24 funds tracked by Wall St. Rank hold HURA as of Q2 2021.

  • Allegiant Private Advisors held 10 shares of TuHURA Biosciences worth $41K as of Q2 2021.
  • Allegiant Private Advisors left its TuHURA Biosciences share count unchanged in Q2 2021.
  • TuHURA Biosciences made up 0.01% of Allegiant Private Advisors's portfolio in Q2 2021, its #164 holding.
  • Allegiant Private Advisors first reported a position in TuHURA Biosciences in Q4 2020 and has held it in 3 quarters since.
  • 24 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2021.

Based on Allegiant Private Advisors's 13F filing for Q2 2021, filed 7 Jul 2021.